1519302728677314561

At this year’s #Tandem22 Meetings we highlighted GDA-201, our lead NAM-enabled natural killer (NK) cell therapy for the treatment of hematologic and solid tumors. Learn more here: https://t.co/VGOT20vZJs https://t.co/aEQ9RKIYdk

Send us a message